Theravance Biopharma, Inc.

MACQUARIE GROUP LTD TBPH

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/13/2025

Shares

208,783

Value ($000)

3,048

Weight

0.0%

2020 Q2 - 2025 Q3 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/13/2025	3,048	0.0%	208,783	9/30/2025
2025 Q1	5/15/2025	1,864	0.0%	208,783	3/31/2025
2024 Q4	2/14/2025	1,965	0.0%	208,783	12/31/2024
2024 Q3	11/14/2024	1,683	0.0%	208,783	9/30/2024
2024 Q2	8/9/2024	1,776	0.0%	209,492	6/30/2024
2024 Q1	5/14/2024	1,873	0.0%	208,783	3/31/2024
2023 Q4	2/14/2024	2,347	0.0%	208,783	12/31/2023
2023 Q3	11/14/2023	1,802	0.0%	208,783	9/30/2023
2023 Q2	10/27/2023	2,161	0.0%	208,783	6/30/2023
2023 Q1	6/1/2023	2,265	0.0%	208,783	3/31/2023
2022 Q4	2/21/2023	2,343	0.0%	208,783	12/31/2022
2022 Q3	11/14/2022	2,177	0.0%	214,079	9/30/2022
2022 Q2	8/17/2022	1,946	0.0%	214,712	6/30/2022
2022 Q1	5/16/2022	2,053	0.0%	214,712	3/31/2022
2021 Q4	2/11/2022	2,373	0.0%	214,712	12/31/2021
2021 Q3	11/12/2021	1,589	0.0%	214,712	9/30/2021
2021 Q2	8/13/2021	4,215	0.0%	290,258	6/30/2021
2021 Q1	5/14/2021	1,663	0.0%	81,475	3/31/2021
2020 Q4	2/16/2021	1,245	0.0%	70,058	12/31/2020
2020 Q3	11/13/2020	760	0.0%	51,383	9/30/2020
2020 Q2	8/11/2020	1,117	0.0%	53,237	6/30/2020